Clin2
NCT06990984Possibly a fitNot yet recruiting

Study of tti-0102 for leigh syndrome

Leigh Syndrome

Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.

This trial tests a new drug, TTI-0102, for people with Leigh syndrome spectrum. The goal is to see if it helps with symptoms and to find the right dose.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
18 people
Ages
5 years to 55 years
Study type
Interventional

Who can take part

  • Age between 5 and 55 years
  • Confirmed diagnosis of Leigh syndrome or Leigh-like disorder with developmental issues
  • Able to swallow the study drug (a liquid)
  • Acceptable liver and kidney function
  • No recent serious infections or other major health problems
  • Willing to use birth control during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06843811Enrolling by invitation· Phase 2
Sirolimus for Leigh Syndrome

This trial tests if sirolimus can help people with Leigh syndrome. It aims to see if the drug can improve neurological symptoms and is looking for participants aged 6 months to 55 years.

Philadelphia, Pennsylvania
NCT03137355Recruiting
Registry for people with Leigh syndrome

This study is a registry that collects information from people diagnosed with Leigh syndrome. It may help researchers understand the condition better and improve future care.

Houston, Texas
NCT06967831Recruiting
Testing existing drugs for mitochondrial disorders

This trial looks at whether drugs already approved for other conditions might help people with Leigh syndrome, a rare mitochondrial disorder. Researchers will study cells made from your skin to see how these drugs work.

Düsseldorf, North Rhine-Westphalia
NCT07837726Not yet recruiting· Phase 2
Study of TTI-0102 for cystinosis

This study tests a new medicine called TTI-0102 for cystinosis. It aims to see if it can help manage cystine levels in the body, which may reduce kidney and other organ damage.

NCT07600658Not yet recruiting· Phase 1/Phase 2
Study of new drug to treat brain symptoms in Timothy syndrome

This trial tests a new medicine for children with Timothy syndrome, a rare genetic condition that can cause heart, developmental, and brain problems. It aims to see if the drug can prevent or ease symptoms like seizures, autism, and developmental delays when started early.

Stanford, California
NCT06776848Recruiting· Phase 1/Phase 2
Lithium for TBR1-related neurodevelopmental disorder

This trial tests whether taking lithium for 2 years can improve symptoms in people with a TBR1 gene change that causes neurodevelopmental challenges. It aims to see if lithium is safe and helpful for this condition.

Dijon

Hear when a new Leigh Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.